Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Sunday, November 22, 2015

CME event "RISKY BUSINESS": Understanding and Attenuating Risk Associated with Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis

Multiple sclerosis (MS) strikes people in the prime of their lives, affecting upwards of 400,000 people in the United States and 2.5 million worldwide. However, a diagnosis of MS is no longer a sentence of doom; “the MS landscape has been comprehensively and irreversibly transformed by progress” in understanding the pathophysiology of the disease and the development of targeted therapy. 

As new therapeutic options become available, establishing effective patient-centric treatment plans, based upon newly identified targets and incorporating mechanism of action, will be increasingly essential to achieving optimum quality of life for all of these individuals.

In this neuroscience CME Live and On Demand faculty will share the evidence and their insights with health care providers to enable them to collaboratively engage patients in a discussion about their disease and develop shared treatment goals to improve outcomes in patients with MS.
Healthcare Providers: Click here to learn more of this event

Keep up to date with the news and information we provide by signing up by clicking here

No comments: